• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aileron Therapeutics, Inc. - Common Stock (NQ:ALRN)

2.110 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.110
Bid (Size) 2.000 (2)
Ask (Size) 2.700 (31)
Prev. Close 2.110
Today's Range 2.110 - 2.110
52wk Range N/A - N/A
Shares Outstanding 4,541,167
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis ↗
November 13, 2024
Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to enhance lung function in IPF patients. 
Via Benzinga
News headline image
ALRN Stock Earnings: Aileron Therapeutics Misses EPS for Q2 2024 ↗
August 15, 2024
ALRN stock results show that Aileron Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace

Performance

More News

Read More
News headline image
ALRN Stock Earnings: Aileron Therapeutics Reported Results for Q1 2024 ↗
May 15, 2024
Via InvestorPlace
News headline image
Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
May 15, 2024
From Aileron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Aileron Therapeutics to Present at Two Upcoming Investor Conferences
May 06, 2024
From Aileron Therapeutics, Inc.
Via GlobeNewswire
BioMedNewsBreaks — Aileron Therapeutics Inc. (NASDAQ: ALRN) Closes Underwritten Registered Direct Offering
May 06, 2024
Via Investor Brand Network
News headline image
Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
May 03, 2024
From Aileron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
May 01, 2024
From Aileron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
May 01, 2024
From Aileron Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
April 18, 2024
Via Benzinga
News headline image
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
April 18, 2024
Via Benzinga
Aileron Therapeutics Inc. (NASDAQ: ALRN) Leading the Way in Thursday Trading Based on Percentage Gain
April 18, 2024
Via Investor Brand Network
News headline image
ALRN Stock Earnings: Aileron Therapeutics Reported Results for Q4 2023 ↗
April 16, 2024
Via InvestorPlace
News headline image
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
April 15, 2024
From Aileron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Aileron Therapeutics Announces CEO Transition
March 12, 2024
From Aileron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event
February 15, 2024
From Aileron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024
February 01, 2024
From Aileron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
January 30, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
January 23, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
January 12, 2024
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
January 12, 2024
Via InvestorPlace
News headline image
Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
December 15, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
December 15, 2023
Via Benzinga
News headline image
Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket ↗
December 15, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
December 15, 2023
Via Benzinga

Frequently Asked Questions

Is Aileron Therapeutics, Inc. - Common Stock publicly traded?
Yes, Aileron Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Aileron Therapeutics, Inc. - Common Stock trade on?
Aileron Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aileron Therapeutics, Inc. - Common Stock?
The ticker symbol for Aileron Therapeutics, Inc. - Common Stock is ALRN on the Nasdaq Stock Market
What is the current price of Aileron Therapeutics, Inc. - Common Stock?
The current price of Aileron Therapeutics, Inc. - Common Stock is 2.110
When was Aileron Therapeutics, Inc. - Common Stock last traded?
The last trade of Aileron Therapeutics, Inc. - Common Stock was at 01/10/25 04:00 PM ET
What is the market capitalization of Aileron Therapeutics, Inc. - Common Stock?
The market capitalization of Aileron Therapeutics, Inc. - Common Stock is 9.58M
How many shares of Aileron Therapeutics, Inc. - Common Stock are outstanding?
Aileron Therapeutics, Inc. - Common Stock has 10M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap